Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Langetermijnresultaten bevestigen fase III-data van cladribine (ECTRIMS 2019 in Stockholm)
okt 2019 | Multipele Sclerose